With the aim of remaining a benchmark in the field of comprehensive management solutions for Anatomic Pathology and healthcare IT, Esblada Medical has implemented a Quality Management System in accordance with the ISO 9001 standard to ensure, maintain and improve the level of service we provide to our customers. We believe our customers continue to place their trust in us because we deliver added value through healthcare solutions designed to improve process management, enhance traceability in diagnostic workflows, provide greater quality control and reduce the costs associated with their activity.
We are focused on providing our customers with a comprehensive service through our software solutions, delivering value and the highest quality while addressing their needs and expectations at all times. To achieve this, we work to deliver and commission each software solution in the shortest possible time, while also providing ongoing maintenance and technical support. We offer our employees and partners the opportunity to take part in the company’s project with stability, security, training and the backing of Esblada Medical. To enable them to uphold the company’s commitment to quality, Management provides the training and resources required to ensure they have the necessary skills and can properly carry out our processes. We go beyond compliance with both legal requirements and our customers’ requirements by applying continuous improvement and innovation. In this regard, each year, as part of the Management Review, we define the company’s quality objectives. We strive to be a leader and benchmark in healthcare technology solutions, focused on the management of Anatomic Pathology processes, both through the innovative nature of our solutions and the quality of our service, as well as by incorporating improvements based on feedback identified, for example, through our customers. This policy is communicated to all company personnel and is reviewed annually as part of the Management Review. Francesc Roig General Manager of Esblada Medical La Garriga, December 16, 2020
